World's Best Scientists 2026 revealed!
Marie-Christine Chartier-Harlin

Marie-Christine Chartier-Harlin

D-Index & Metrics

Biology and Biochemistry

D-Index
57
Citations
20624
World Ranking
13539
National Ranking
514

Marie-Christine Chartier-Harlin publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Marie-Christine Chartier-Harlin sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 153 publications — 28th percentile

28% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Marie-Christine Chartier-Harlin D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Marie-Christine Chartier-Harlin sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 57 D-Index — 31st percentile

31% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Marie-Christine Chartier-Harlin is affiliated with the University of Lille in France and has a research portfolio primarily focused on neurological diseases, particularly Parkinson's disease. Their work spans multiple intersecting fields including Medicine, Biochemistry, Genetics and Molecular Biology, with significant contributions to Neurology and Molecular Biology.

Their research encompasses the following main topics:

  • Parkinson's Disease Mechanisms and Treatments
  • Cellular transport and secretion
  • Lysosomal Storage Disorders Research
  • Neurological diseases and metabolism
  • Alzheimer's disease research and treatments
  • Fungal and yeast genetics research
  • Genetic Neurodegenerative Diseases

Key recent publications by Marie-Christine Chartier-Harlin include:

  • "Glycosphingolipids and neuroinflammation in Parkinson's disease" (2020), published in Molecular Neurodegeneration
  • "Transcriptomic signatures of brain regional vulnerability to Parkinson's disease" (2020), published in Communications Biology
  • "LRRK2 Phosphorylation, More Than an Epiphenomenon" (2020), published in Frontiers in Neuroscience
  • "Genome-wide Association and Meta-analysis of Age at Onset in Parkinson Disease" (2022), published in Neurology
  • "Mendelian Randomisation Study of Smoking, Alcohol, and Coffee Drinking in Relation to Parkinson's Disease" (2021), published in Journal of Parkinson's Disease

The scientist frequently collaborates with notable coauthors, including:

  • Jean-Marc Taymans (18 joint publications)
  • Eugénie Mutez (14 joint publications)
  • Ekaterina Rogaeva (7 joint publications)
  • Pau Pástor (7 joint publications)
  • Ashwin Ashok Kumar Sreelatha (6 joint publications)

Marie-Christine Chartier-Harlin's work appears regularly in several scientific journals and publication venues such as:

  • bioRxiv (Cold Spring Harbor Laboratory) with 5 publications
  • Cells with 4 publications
  • Movement Disorders with 3 publications
  • Frontiers in Neuroscience with 2 publications
  • Neurology with 2 publications

Their research integrates subfields including Neurology, Molecular Biology, Cell Biology, Physiology, and Cellular and Molecular Neuroscience. This multidisciplinary approach supports investigations into cellular transport systems, neuroinflammatory pathways, and genetic underpinnings of neurodegenerative diseases.

Best Publications

  • Segregation of a missense mutation in the amyloid precursor protein gene with familial Alzheimer's disease.

    Alison Goate;Marie-Christine Chartier-Harlin;Mike Mullan;Jeremy Brown

  • α-synuclein locus duplication as a cause of familial Parkinson's disease

    Marie-Christine Chartier-Harlin;Jennifer M. Kachergus;Christophe Roumier;Vincent Mouroux

  • Early-onset Alzheimer's disease caused by mutations at codon 717 of the β-amyloid precursor protein gene

    Marie Christine Chartier-Harlin;Fiona Crawford;Henry Houlden;Andrew Warren

  • Collaborative analysis of alpha-synuclein gene promoter variability and Parkinson disease.

    Demetrius M. Maraganore;Mariza De Andrade;Alexis Elbaz;Matthew J. Farrer

  • Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: analysis of the 19q13.2 chromosomal region.

    Chartier-Harlin Mc;Parfitt M;Parfitt M;Legrain S;Pérez-Tur J

  • A full genome scan for late onset Alzheimer's disease

    Patrick Kehoe;Fabienne Wavrant-De Vrieze;Richard Crook;William S. Wu

  • Translation initiator EIF4G1 mutations in familial Parkinson disease

    Marie Christine Chartier-Harlin;Marie Christine Chartier-Harlin;Justus C. Dachsel;Carles Vilariño-Güell;Sarah J. Lincoln

  • Genomic investigation of alpha-synuclein multiplication and parkinsonism

    Owen A. Ross;Adam T. Braithwaite;Lisa M. Skipper;Jennifer Kachergus

  • Association of LRRK2 exonic variants with susceptibility to Parkinson's disease: a case-control study.

    Owen A. Ross;Alexandra I. Soto-Ortolaza;Michael G. Heckman;Jan O. Aasly

  • UCHL1 is a Parkinson's disease susceptibility gene

    Demetrius M. Maraganore;Timothy G. Lesnick;Alexis Elbaz;Marie Christine Chartier-Harlin

  • A New Polymorphism in the Apoe Promoter Associated with Risk of Developing Alzheimer's Disease

    Jean-Charles Lambert;Florence Pasquier;Dominique Cottel;Bernard Frigard

  • CYP2D6 polymorphism, pesticide exposure, and Parkinson's disease.

    Alexis Elbaz;Clotilde Levecque;Jacqueline Clavel;Jean-Sébastien Vidal

  • Therapeutic potential of autophagy-enhancing agents in Parkinson's disease

    Tim E. Moors;Jeroen J M Hoozemans;Angela Ingrassia;Tommaso Beccari

  • Independent association of an APOE gene promoter polymorphism with increased risk of myocardial infarction and decreased APOE plasma concentrations—the ECTIM Study

    Jean-Charles Lambert;Thierry Brousseau;Véronique Defosse;Alun Evans

  • Pronounced Impact of Th1/E47Cs Mutation Compared With −491 at Mutation on Neural APOE Gene Expression and Risk of Developing Alzheimer's Disease

    Jean-Charles Lambert;Claudine Berr;Florence Pasquier;André Delacourte

  • Apolipoprotein E and Alzheimer disease: genotype-specific risks by age and sex

    H Bickeböller;D Campion;A Brice;P Amouyel

  • A novel presenilin-2 splice variant in human Alzheimer's disease brain tissue.

    Naoya Sato;Osamu Hori;Atsushi Yamaguchi;Jean‐Charles Lambert

  • Association between Parkinson's disease and polymorphisms in the nNOS and iNOS genes in a community-based case–control study

    Clotilde Levecque;Alexis Elbaz;Jacqueline Clavel;Florence Richard

  • Contribution of APOE promoter polymorphisms to Alzheimer's disease risk.

    J. C. Lambert;L. Araria-Goumidi;L. Myllykangas;C. Ellis

  • NADPH oxidases in Parkinson’s disease: a systematic review

    Karim Belarbi;Elodie Cuvelier;Alain Destée;Bernard Gressier

Frequent Co-Authors

Alain Destée
Alain Destée University of Lille
John Hardy
John Hardy University College London
Alison Goate
Alison Goate Icahn School of Medicine at Mount Sinai
Matthew J. Farrer
Matthew J. Farrer University of Florida
Jordi Pérez-Tur
Jordi Pérez-Tur Spanish National Research Council
Alexis Elbaz
Alexis Elbaz Versailles Saint-Quentin-en-Yvelines University
Michael Mullan
Michael Mullan Roskamp Institute
André Delacourte
André Delacourte University of Lille
John P. A. Ioannidis
John P. A. Ioannidis Stanford University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

As you explore studying Biology and Biochemistry in the USA, it’s essential to consider related online degrees and evolving career options. Many students pair their science backgrounds with advanced degrees in healthcare management or informatics. For those looking for affordable options, several universities offer the cheapest online mba healthcare programs, making it easier to advance your education without a significant financial burden.

Another growing field for science graduates is medical coding and billing. Understanding the difference between ccs vs cpc certification is crucial, as each certification opens doors to different roles and salary prospects. Curious about earning potential? Find out what is medical coding salary to get a sense of the financial stability this career can offer.

While technology is rapidly changing the healthcare landscape, you might wonder, is medical coding a dying career? The demand remains strong as healthcare data continues to expand. Exploring these pathways can help you align your degree with real-world opportunities, making your education even more valuable.

Best Scientists Citing Marie-Christine Chartier-Harlin

Trending Scientists

Recently Published Articles